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Available online 17 September 2016Antibiotic resistance is a complex global health challenge. The recent Global Action Plan on antimicrobial resis-
tance highlights the importance of adopting OneHealth approaches that can cross traditional disciplinary bound-
aries. We report on the early experiences of a multisectoral Sino-Swedish research project that aims to address
gaps in our current knowledge and seeks to improve the situation through system-wide interventions. Our re-
search project is investigating antibiotic use and resistance in a rural area of China through a combination of ep-
idemiological, health systems and laboratory investigations. We reﬂect here on the challenges inherent in
conducting long distance cross-disciplinary collaborations, having now completed data and sample collection
for a baseline situation analysis. In particular, we recognise the importance of investing in aspects such as effec-
tive communication, shared conceptual frameworks and leadership. We suggest that our experiences will be in-
structive to others planning to develop similar international One Health collaborations.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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It has become evident in recent years that we need to take a holistic
approach to understand the complex global health issue of antibiotic re-
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. This is an open access article underessential knowledge, but there is a need for a collaborativemultisectoral
approach that can deepen our understanding of the underlying dynam-
ics – how bacteria, resistance genes and antibiotics are continuously
ﬂowing between humans, animals and the environment and how
these might be inﬂuenced by various factors [1–5].
One Health is the collaborative effort of multiple disciplines –work-
ing locally, nationally, and globally – to attain optimal health for people,
animals and the environment [6]. In this article we describe a Sino-
Swedish One Health research project that addresses gaps in our current
knowledge through a cross-disciplinary collaboration, and seeks to im-
prove the situation through system-wide interventions. We also illus-
trate the early experiences of this project, called ‘The Sino-Swedish
Integrated Multisectoral Partnership for Antibiotic Resistance Contain-
ment’ (IMPACT), which involves institutions in both China and Sweden.
We do this with a view to contributing to the limited discourse so far on
cross-country multisectoral collaborations in One Health.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Partner institutions in IMPACT.
China Sweden
Zhejiang University (PI) Public Health Agency of Sweden (PI)
China Agricultural University (co-PI) Karolinska Institutet (co-PI)
Shandong University (co-PI) Linköping University (co-PI)
Shandong Academy of Agricultural Science National Food Agency
Shandong Center for Disease Control and
Prevention
National Veterinary Institute
140 O. Cars et al. / One Health 2 (2016) 139–1432. The context for a one health research project in China
China is one of the largest producers and consumers of antibiotics in
the world [7] and high levels of resistant bacteria have been isolated in
surveillance programmes and research studies [8–13].
The IMPACT research project is being conducted at a time when an-
tibiotic resistance is gaining increasing attention at the highest of polit-
ical levels globally, as well as in China [14,15]. The Chinese government
has increasingly recognised the challenges that antibiotic resistance
pose, has started to take actions across many sectors [15] and has re-
leased several policies at a national level for human healthcare [14,16].
As Xiao et al. explain, implementation of these policies have included
extensive use of targets, production of guidelines and formulary restric-
tions, improved education, and liability assignment to institutions and
even individuals [15]. There have been clear successes in reducing inap-
propriate antibiotic use in the past few years, but as these policies have
largely been focussed on hospital care in urban areas, it is less clear how
much of an effect they have had on the situation in rural populations
[17,18]. These policies are linked to and embedded within China's
huge and complex set of on-going healthcare reforms.
In recent years both theMinistry of Science and Technology (MOST)
and Ministry of Agriculture (MOA) have begun to recognise the inﬂu-
ence of animal husbandry on environmental ecology, with research
funding being allocated to improve basic knowledge and control mech-
anisms [7]. National surveillance efforts have started for antibiotic resis-
tance in bacteria from animal origins, and for drug residues on farms.
The government is developing methods tomonitor antibiotic use in ag-
riculture, as well as plans to evaluate the presence of drug residues and
resistance elements in the environment more broadly. The current ef-
fectiveness of policies for improving antibiotic use in animal husbandry
is hindered by the extremely large populations of animals involved,
fragmented systems, and the structural changes currently occurring
with large scale intensive production rapidly replacing family farms
and back-yard production [19,20].
Further challenges to implementation of policies relevant to antibi-
otic resistance in China include on-going rapid mass urbanisation, a
poorly educated ageing rural population, and a lack of microbiology fa-
cilities and expertise for standardised culturing and susceptibility test-
ing of bacteria; however, the development of national policies in
several sectors, increasing scientiﬁc excellence, and rising public con-
cern for food safety all represent opportunities to improve the situation.
Furthermore, the structural changes in both human healthcare and ag-
ricultural sectors may themselves provide opportunities for improving
previous behaviours and practices.
3. Collaborations between China and Sweden
Addressing antibiotic resistance has long featured on the political
agenda in Sweden. This is exempliﬁed by the early banning of antibi-
otics as growth promoters in animal husbandry in 1986, and by the im-
plementation of national collaborative multisectoral policies against
antibiotic resistance in 1995 (Strama, the Swedish Strategic Programme
Against Antibiotic Resistance) [21]. The Swedish Government and its
agencies have made substantial funding available for research projects
and other initiatives that address various aspects of antibiotic resistance.
This funding has frequently aimed to stimulate and support internation-
al collaborations, recognising that antibiotic resistance is a global con-
cern, and one that cannot be managed within a single country [10,18,
22–24].
In 2006, the Chinese and Swedish governments formed aMemoran-
dum of Understanding on several areas within the health sector, and a
Plan of Action speciﬁcally emphasising cooperation on antibiotic resis-
tance was signed by the Chinese and Swedish health ministers in
2010 [25]. In 2012, aMemorandum of Understanding on agriculture co-
operation was signed between the Ministry of Agriculture of China and
the Ministry for Rural Affairs in Sweden, supporting enhancedcooperation and knowledge exchange within the ﬁeld of antibiotic re-
sistance and use [26].
Projects investigating antibiotic use and resistance in China were
launched and reported, identifying high levels of ESBL bacteria in rural
settings, gaps in knowledge about antibiotics in rural caregivers and
rural doctors, and describing recent trends in antibiotic usage across
several provinces [10,18,27]. The political support extended to the Na-
tional Natural Science Foundation of China (NSFC) and the Swedish Re-
search Council (SRC), who co-hosted a workshop on antibiotic
resistance in Beijing inMay 2013, and formed a joint funding call for re-
search collaborations between the two countries [28]. We report here
on one of the funded projects.
4. IMPACT – purpose and scope
IMPACT is amultisectoralﬁve-year research project that investigates
antibiotic use and resistance in a rural area of China using a One Health
approach. This project involves institutions in China and Sweden that
span several sectors (Table 1). The governmental authorities on both
sides participate as scientiﬁc partners. Some of the partners have previ-
ously collaborated on smaller-scale research projects [10,18,27].
The IMPACT research project consists of epidemiological and health
systems investigations, as well as laboratory analyses. It includes four
phases: (i) Joint problem formulation around a One Health approach
to antibiotic resistance, involving all partner institutions; (ii) A baseline
situation analysis in a rural area in China, investigating the present situ-
ation of knowledge, attitudes, practices and perceptions on antibiotic
use and antibiotic resistance across human, animal and environment
sectors; (iii) Design and implementation of a package of multi-faceted
context-speciﬁc interventions to prevent infections, improve antibiotic
use in humans and animals, and limit the spread of resistant bacteria
in this rural area; (iv) Evaluation of the interventions through a repeat-
ed situation analysis. The research goals of IMPACT are listed in Table 2.
We have chosen to conduct this research in a rural area because it is
likely to provide a more deﬁned and stable environment in terms of
population than an urban setting would over the duration of the
study. In addition, there are household pigs living in close proximity
to humans, and there are good local systems in place that can help sup-
port development and implementation of interventions. The project in-
cludes a secondary care hospital in a nearby town as well as twelve
villages (six intervention and six control villages), pragmatically select-
ed from the 73 villages surrounding the central town in the selected dis-
trict. In total 780 households are included in the investigations. In
addition to the households, we areworkingwith village doctors and an-
imal health advisors in the villages, through the support from local Cen-
ters for Disease Control and Prevention. The research project will use
context-adapted versions of previously used methods, including inves-
tigations of commensal microbiota from humans, animals and the envi-
ronment, as well as clinical bacterial isolates from the secondary care
hospital [10,22,29–31]; measurements of antibiotic use for humans
and animals at household and village level, and in the secondary care
hospital [32,33]; and assessments of the knowledge, attitudes, practices
and perceptions of antibiotic prescribers, dispensers and consumers [27,
33].
This is a mixed methods project, and the expected outcomes are
both qualitative and quantitative. Examples of measurable outcomes
Table 2
Research goals of IMPACT.
• To increase basic knowledge and understanding of the complex routes of dis-
semination of antibiotic resistance between different sectors (humans, animals
and the environment) by a multisectoral and bilateral approach
• To increase basic knowledge and understanding of factors contributing to
irrational use of antibiotics in humans and animals
• To integrate the resultant knowledge with existing evidence to design and pilot
interventions aiming to limit development and spread of antibiotic resistance
• To promote adequate infection prevention and control and access to effective
antibiotics for humans and animals for improved public and animal health and
consequently efﬁcient, sustainable animal food production
Table 3
Successes and challenges of the IMPACT project, and our strategies tomeet the challenges.
Successes and challenges of One
Health research projects [41]
Strategies to meet the challenges
Effective communication • Annual meetings attended by all, including
educational presentations, training
workshops, and site visits
• Separate meetings to review progress
• Day to day communication centred on the
working groups (online conferencing, tele-
phone calls and email)
Education • Educational sessions at annual meetings
help share discipline-speciﬁc terminologies,
methodologies and experiences; particular-
ly important for junior members
Conﬂict among disciplines • The project includes a large group of re-
searchers who have interpersonal charac-
teristics conducive to collaboration perhaps
as a result of careful initial selection
• We aim to give all sectors equal importance
Shared conceptual frameworks • The most important conceptual framework
has been elaborating the value of a One
Health approach, and this has been present-
ed at several meetings
• Joint protocols, including protocols for labo-
ratory work
Leadership • The collaboration includes two PIs (one in
China, one in Sweden), supported by four
co-PIs (two in China, two in Sweden)
• Each working group has one named leader
in China and one in Sweden
Perceived power differentials • Differences often manifest through invisible
features of work and daily interaction, and a
key undertaking is to make these features
more visible to individual researchers, to
reduce the potential feelings of division
Community-based methodologies • We collaborate with local practitioners to
organise infrastructural support
Time and effort required for
maintaining and establishing
research teams
• We have found time to be a necessary
investment, with a period of over twelve
months elapsing between funds being
awarded and the ﬁrst samples being collected
• The establishment of smaller working groups
(see Table 4) was crucial
Support for transdisciplinary
research
• Financial support for the project was granted
• Early in the research development process
we discussed expected publications, and how
individual contributions might be recognised
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environment) and overlap of resistance phenotypes and genotypes be-
tween sectors. Other measurable outcomes include assessing the rela-
tionship between presence of a backyard farm in households and the
residents' knowledge, attitudes and practices regarding antibiotics;
quantifying monthly household usage of antibiotic for humans and
pigs; and describing patterns of antibiotics prescribed in village clinics.
Results will be compared before and after themultifaceted intervention
and between intervention and control villages. Furthermore, we antici-
pate that the local infrastructure and collaborations created to deliver
the One Health intervention can be used in future efforts to improve an-
tibiotic use and contain antibiotic resistance.
5. Operationalising one health
The world has become deeply interconnected: we observe mass
movements of humans and global trade of food, with an increase in
urban centers and the formation of funnel points in the food production
industry. A One Health approach is now needed to help develop our un-
derstanding of antibiotic resistance [1,2]. The World Health Organisa-
tion (WHO), World Organisation for Animal Health (OIE) and the
Food and Agriculture Organisation of the United Nations (FAO) all rec-
ognise the centrality for OneHealth approaches in tackling antibiotic re-
sistance, as demonstrated by the tripartite concept note and the WHO
global action plan on antibiotic resistance, where the OIE and FAO
have distinct roles [34–37].
At its heart, One Health is a collaborative effort [5,6]. How we inter-
pret and operationalise this collaborative effort in real world research
has important implications for the value that IMPACT can deliver. Single
discipline and multidisciplinary investigations are vital to generate
knowledge relevant to speciﬁc situations; integrating the results to pro-
duce a deeper understanding of the underlying dynamics as well as ten-
tative solutions is an additional challenge. Cross-disciplinary thinking
can more easily recognise how different structures and feedback loops
are shared betweendisciplines [38–40]. As examples, a rural farmer's un-
derstanding of antibiotic use in his pigs will likely have implications for
how he treats his children when they are ill; and drugstore regulations
designed to improve antibiotic use in humans may have consequences
for antibiotic use in animals if they are introduced in drugstores that
serve both markets.
Our intention of using a multisectoral approach in IMPACT is to ad-
dress important research questions that individual discipline investiga-
tions are not able to, either through observational evidence or
methodological developments. By using a One Health approach the in-
terventions, for instance, will be strengthened by being more holistic
and realistic. As an example, we will design education sessions on
human hygiene together with sessions on hygiene in household farms.
Examples of research questions within IMPACT are “Who inﬂuences
total antibiotic use within a community, and what are their knowledge
and attitudes towards antibiotic resistance?”; “How do antibiotic drugs
‘move’ within a selected geographical area?”; “To what extent are
clones of resistant bacteria and genetic resistance elements similar
within and between different sectors and geographical locations?” and“What are the similarities/differences of clones of resistant bacteria
and genetic resistance elements between people, animals and the
environment?”.
6. Challenges of cross-country cross-disciplinary one health
collaborations
As cross-disciplinary One Health research programmes are a rela-
tively recent concept, there are few published reports that can help
guide the development of a new project. Min et al. conducted a scoping
reviewof the limited literature and identiﬁed key elements contributing
to the challenges and successes of such projects (see Table 3) [41]. Using
this as a framework, we present some of our experiences from the ﬁrst
two years of the IMPACT project, and mention two additional themes
that we feel are particularly relevant to international collaborations in
this context: culture and geographical separation.
6.1. Communication
Effective communication is central to the success of IMPACT, but also
lies at the root of some of the challenges encountered. Crucially, thema-
jority of our communication cannot take place in person. So far we have
organised annual meetings in China and Sweden, attended by all
142 O. Cars et al. / One Health 2 (2016) 139–143individuals involved in IMPACT, as well as several separate visits with
smaller numbers of researchers to focus on speciﬁc project tasks. The
annual meetings include educational presentations, training work-
shops, and site visits. Chinese institutions and Swedish institutions
have also met separately, roughly every six months to review progress.
Day to day communication between these largermeetings is centred on
working groups that are responsible for different project components
(see Table 4 for a list of working groups prior to the ﬁrst data collection;
the composition was then adapted for the analytical phase). Most re-
searchers are members of multiple working groups. These groups
have used online conferencing, telephone calls and email. The discus-
sions are mostly conducted in English, with Chinese translation when
needed. The complexity of theprojectmeans that individuals have occa-
sionally not been available to take part in certain conversations, so there
is a regular need for reviews to ensure that everyone is aware of key
developments.
China and Sweden are separated by 7000 km and a time difference
of six or seven (7) hours, depending on the time of year. These distances
exacerbate several of the challenges described above, in particular our
communication. We interact less frequently than we would with a
smaller separation, and we make more use of communication methods
such as email that are asynchronous. Our exchanges often proceed in
step-like increments rather than ﬂowing as a conversation; we also
relymore heavily on the textual content of messages than on nonverbal
contents such as tone of expression and body language [42], and this has
sometimes led to communication errors. We must also recognise that
international research collaborations have a crucial role to play in
supporting the transfer of research methodologies between geographi-
cally separated settings, despite these challenges [43].
6.2. Meeting the challenges
We have used educational sessions at our annual meetings to help
share discipline-speciﬁc terminologies, methodologies and experiences
and to move towards common understanding of the complex issues at
hand. This has been particularly important for the junior members of
the research teams, many of whom have little previous exposure to
other disciplines. Conceptual frameworkswere discussed in the drafting
of the original funding application. It has been useful to subsequently re-
turn to these, particularly when a single discipline would usually inves-
tigate a research question in a different manner. The most important
conceptual framework has been elaborating the value of a One Health
approach, and this has been presented at several meetings.
The IMPACT collaboration includes two principal investigators (PIs),
one in China and one in Sweden, who maintain the project's focus on
the bigger picture. They are supported by four co-PIs (two in China,
two in Sweden). The PI/co-PI group holds monthly meetings, and the
minutes are shared with all IMPACT researchers for transparency and
trust. In addition, each working group has one named leader in China
and one in Sweden. We also have a senior advisor who focuses more
on broader observations of the project and its progress.
Many researchers have reported that additional time and effort is
needed when conducting cross-disciplinary research [41]. We have
also found this to be a necessary investment, with a period of over
twelve months elapsing between funds being awarded and the ﬁrstTable 4
Working groups in IMPACT, prior to ﬁrst data collection.
• Location and participant selection working group
• Questionnaire development working group
• Antibiotic usage data working group
• Hospital working group
• Microbiology and media selection working group
• Environment working group
• Logistics working group
• Data labelling working groupsamples being collected. Therewas amixture of expectations among dif-
ferent partners as to how long this period would take, recognising that
certain project components require longer to plan than others. In retro-
spect, it would have helped for us to be more open about our different
expectations early on. We have found that reporting requirements set
by some funders do not currently recognise the need for such a long pe-
riod of planning in large collaborative projects. This time and effort also
brings opportunities: innovations frequently occur at disciplinary inter-
faces, side projectsmaydevelopwithin themainproject, and smaller col-
laborations may emerge that will outlast the formal research project.
As Larson et al. describe, we become socialised professionally in dif-
ferentways as researchers [44]. These differences oftenmanifest through
invisible features of work and daily interaction, such as preferred length
of meeting times, comfort with uncertainty, and positioning of junior
members within a research team. International collaborations face the
additional challenge of individuals working and communicating from
different cultural backgrounds. A key undertaking is to make these
features more visible to individual researchers. This can help reduce
the potential feelings of division that arise between individuals from dif-
ferent countries, as well as the frustration from being unable to identify
where the tensions originate.
As the number and diversity of participants in a cross-disciplinary
collaboration increases, the project naturally becomes more complex.
Participants are not passive, however, so it can start to behave as its
own complex adaptive system that evolves over the course of the re-
search project [45,46]. As the collaboration grows in size there is a risk
that any one person feels less individual responsibility and ownership
for the whole, particularly when many components are outside their
area of expertise. In many ways the success and survival of the collabo-
ration is dependent on purposefully cultivating an ability within the
complex adaptive system to respond to the various challenges it may
encounter. This requires effectivemanagement of information ﬂows be-
tween all sub-systems and individuals, combined with an on-going
awareness of the role each person is playing in the wider system.
7. Conclusions and implications
Resistant bacteria, genetic resistance elements and antibiotics are
not limited by disciplinary or geographical boundaries.Multisectoral re-
search collaborations such as IMPACT mirror this concept, and are en-
couraged by the recent shift towards the One Health approach in
addressing antibiotic resistance.
In today's globalised world the individual researcher is increasingly
working in large multi-disciplinary or multisectoral consortia. Chal-
lenges in such collaborations require researchers to be open-minded
and less concernedwith protecting their own scientiﬁc area. Everybody
involved in the IMPACT project, at all levels in China as well as in Swe-
den, have beenmade aware of the challenges inworking internationally
and across sectors, as we tackle these meta-questions in a transparent
and structured way. Succeeding in this “project within the project” is a
prerequisite for obtaining results that have a true impact on the contin-
ued global engagement against the spread of antibiotic resistance.
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